Pathogenetic therapy of COVID-19: focus on glucocorticoids

التفاصيل البيبلوغرافية
العنوان:	Pathogenetic therapy of COVID-19: focus on glucocorticoids
المؤلفون:	M.V. Bondar, M.M. Pilipenko, T.V. Ovsiienko, O.A. Loskutov
المصدر:	Медицина неотложных состояний, Vol 18, Iss 2, Pp 6-12 (2022)
بيانات النشر:	Zaslavsky O.Yu., 2022.
سنة النشر:	2022
المجموعة:	LCC:Medical emergencies. Critical care. Intensive care. First aid
مصطلحات موضوعية:	covid-19, systemic inflammatory response, pro-inflammatory cytokines, hypothalamo-pituitary-adrenal system, glucocorticoids, review, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
الوصف:	The problem of preventing excessive production of pro-inflammatory cytokines in the case of COVID-19 remains unresolved. The use of steroids in the treatment of coronavirus pneumonia remains controversial. To date, there is insufficient literature data for the routine use of steroids in COVID-19 intensive care programs, and this issue remains the subject of continuous research and endless debate. The review of the scientific literature focuses on one of the areas of pathogenetic therapy for COVID-19 — the prevention and elimination of hyperproduction of pro-inflammatory cytokines using glucocorticoid drugs. The review presents modern international recommendations on the use of glucocorticoid drugs in severe COVID-19, examines the pathogenetic mechanisms of their action and side effects.
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English Ukrainian
تدمد:	2224-0586 2307-1230
Relation:	https://emergency.zaslavsky.com.ua/index.php/journal/article/view/1466; https://doaj.org/toc/2224-0586; https://doaj.org/toc/2307-1230
DOI:	10.22141/2224-0586.18.2.2022.1466
URL الوصول:	https://doaj.org/article/80495ba6767c4c0593e74614ff1a1a71
رقم الانضمام:	edsdoj.80495ba6767c4c0593e74614ff1a1a71
قاعدة البيانات:	Directory of Open Access Journals

View record in DOAJ

الوصف
تدمد:	22240586 23071230
DOI:	10.22141/2224-0586.18.2.2022.1466